The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kalakutskiy N.V.

First St. Petersburg State Medical University named after I.P. Pavlova

Baranova I.B.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Ovsepian T.N.

First St. Petersburg State Medical University named after I.P. Pavlova

Rybakova M.G.

Pavlov First Saint Petersburg State Medical University

Kasimova N.D.

First St. Petersburg State Medical University named after I.P. Pavlova

Non-Langengars type of sinus histiocytosis with maxillofacial skin lesions (Rosai—Dorfman disease). Clinical case description

Authors:

Kalakutskiy N.V., Baranova I.B., Ovsepian T.N., Rybakova M.G., Kasimova N.D.

More about the authors

Journal: Stomatology. 2021;100(3): 90‑95

Read: 7241 times


To cite this article:

Kalakutskiy NV, Baranova IB, Ovsepian TN, Rybakova MG, Kasimova ND. Non-Langengars type of sinus histiocytosis with maxillofacial skin lesions (Rosai—Dorfman disease). Clinical case description. Stomatology. 2021;100(3):90‑95. (In Russ.)
https://doi.org/10.17116/stomat202110003190

References:

  1. Aubart FC, Haroche J, Emile J-F, Charlotte F, Barete S, Schleinitz N, Donadieu J, Amoura Z. Rosai-Dorfman disease: Diagnosis and therapeutic challenges. Rev Med Interne. 2018;39(8):635-640.  https://doi.org/10.1016/j.revmed.2018.02.011.
  2. Khan AA, Siraj F, Rai D, Aggarwa S. Rosai-Dorfman disease of the paranasal sinuses and orbit. Hematol Oncol Stem Cell Ther. 2011;4(2):94-96.  https://doi.org/10.5144/1658-3876.2011.94.
  3. Colmenero I, Molho-Pessach V, Torrelo A, Zlotogorski A, Requena L. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease. Am J Dermatopathol. 2012;34(3):315-320.  https://doi.org/10.1097/DAD.0b013e31823b99fc.
  4. Cai Y, Shi Z, Bai Y. Review of Rosai-Dorfman disease: new insights into the pathogenesis of this rare disorder. Acta Haematol. 2017;138(1):14-23.  https://doi.org/10.1159/000475588.
  5. Shanmugam V, Margolskee E, Kluk M, Giorgadze T, Orazi A. Rosai-Dorfman disease harboring an activating KRAS K117 N missense mutation. Head Neck Pathol. 2016;10(3):394-399.  https://doi.org/10.1007/s12105-016-0709-6. Epub 2016 Feb 27.
  6. Matter MS, Bihl M, Juskevicius D, Tzankov A. Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease. Virchows Arch. 2017;471(4):6545-547.  https://doi.org/10.1007/s00428-017-2173-4.
  7. Cobanoglu N, Galip N, Dalkan C, Comunoglu C, Bahceciler N. Rosai-Dorfman disease presenting as mediastinal lymphadenopathy: case report and review of the literature. Paediatr Int Child Health. 2013;33(2):120-123.  https://doi.org/10.1179/2046905512Y.0000000025
  8. Haroche J, Charlotte F, Arnaud L, Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, EmileHigh JF. Prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;20(13):2700-2703. https://doi.org/10.1182/blood-2012-05-430140.
  9. AlWadani S, Robinson S, Myers R, Akpek EK, Eberhart CG. No increase in IgG4-positive plasma cells in limbal Rosai-Dorfman disease. Cornea. 2014;33(8):844-847.  https://doi.org/10.1097/ICO.0000000000000141
  10. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol. 2017;30(10):1367-1377. https://doi.org/10.1038/modpathol.2017.55
  11. Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol. 2005;29(7):903-911.  https://doi.org/10.1097/01.pas.0000157997.61177.08
  12. Shrirao N, Sethi A, Mukherjee B. Management Strategies in Rosai-Dorfman Disease: To Do or Not To Do. J Pediatr Hematol Oncol. 2016;38(7):248-250.  https://doi.org/10.1097/MPH.0000000000000526
  13. Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, Villivà N, Mandelli F. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol. 2002;69(1):67-71.  https://doi.org/10.1002/ajh.10008
  14. Al-Khateeb TH. Cutaneous Rosai-Dorfman Disease of the Face: A Comprehensive Literature Review and Case Report. J Oral Maxillofac Surg. 2016; 74(3):528-540.  https://doi.org/10.1016/j.joms.2015.09.017
  15. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of theentity. Semin Diagn Pathol. 1990;7(1):19-73. PMID: 2180012 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.